About Ypsomed
Ypsomed is a company based in Burgdorf (Switzerland) founded in 2001 was acquired by Techmed in April 2025.. Ypsomed has raised $7.45 million across 1 funding round from investors including BV Partners and TecMed Deutschland. The company has 2,640 employees as of March 31, 2024. Ypsomed offers products and services including Ypsomed Delivery Systems, Ypsomed Diabetescare, and YpsoPump. Ypsomed operates in a competitive market with competitors including Tandem Diabetes, Insulet, Valeritas, Kaleido and CeQur, among others.
- Headquarter Burgdorf, Switzerland
- Employees 2640 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ypsomed Holding Ag
-
Annual Revenue
$826.6 M (USD)36.54as on Mar 31, 2024
-
Net Profit
$96.58 M (USD)11.66as on Mar 31, 2024
-
EBITDA
$235.02 M (USD)36.55as on Mar 31, 2024
-
Total Equity Funding
$7.45 M (USD)
in 1 rounds
-
Latest Funding Round
$7.45 M (USD), Series A
Jun 01, 2003
-
Investors
BV Partners
& 1 more
-
Employee Count
2640
as on Mar 31, 2024
-
Acquired by
Techmed
(Apr 24, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ypsomed
Ypsomed is a publicly listed company on the SIX with ticker symbol YPSN in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Ypsomed
Ypsomed offers a comprehensive portfolio of products and services, including Ypsomed Delivery Systems, Ypsomed Diabetescare, and YpsoPump. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technologies for reliable self-medication injection devices.
Products for easy diabetes self-treatment and monitoring.
Simple insulin pump system for diabetes management.
Unlock access to complete
Unlock access to complete
Funding Insights of Ypsomed
Ypsomed has successfully raised a total of $7.45M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.45 million completed in June 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $7.4M
-
First Round
First Round
(01 Jun 2003)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2003 | Amount | Series A - Ypsomed | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ypsomed
Ypsomed has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include BV Partners and TecMed Deutschland. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity financing is offered by BV Partners for businesses.
|
Founded Year | Domain | Location | |
|
TecMed Deutschland GmbH is focused on producing insulin pump components.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ypsomed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ypsomed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ypsomed Comparisons
Competitors of Ypsomed
Ypsomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tandem Diabetes, Insulet, Valeritas, Kaleido and CeQur, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of devices for continuous glucose monitoring and manual insulin delivery
|
|
| domain | founded_year | HQ Location |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| domain | founded_year | HQ Location |
Wearable insulin patch pumps are developed for transdermal delivery.
|
|
| domain | founded_year | HQ Location |
Insulin pumps and monitoring software for diabetes are developed.
|
|
| domain | founded_year | HQ Location |
Wearable insulin delivery patches are developed for mealtime dosing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ypsomed
Frequently Asked Questions about Ypsomed
When was Ypsomed founded?
Ypsomed was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Where is Ypsomed located?
Ypsomed is headquartered in Burgdorf, Switzerland. It is registered at Burgdorf, Bern, Switzerland.
Is Ypsomed a funded company?
Ypsomed is a funded company, having raised a total of $7.45M across 1 funding round to date. The company's 1st funding round was a Series A of $7.45M, raised on Jun 01, 2003.
How many employees does Ypsomed have?
As of Mar 31, 2024, the latest employee count at Ypsomed is 2,640.
What is the annual revenue of Ypsomed?
Annual revenue of Ypsomed is $826.6M as on Mar 31, 2024.
What does Ypsomed do?
Ypsomed was founded in 2001 in Burgdorf, Switzerland, where injection systems for self-medication and diabetes care products are developed and manufactured. The portfolio encompasses blood glucose monitoring systems, pen needles, safety devices, and infusion systems. Operations focus on the medical device sector, supplying tools for diabetes management and self-administration across global markets.
Who are the top competitors of Ypsomed?
Ypsomed's top competitors include Tandem Diabetes, Insulet and Kaleido.
What products or services does Ypsomed offer?
Ypsomed offers Ypsomed Delivery Systems, Ypsomed Diabetescare, and YpsoPump.
Is Ypsomed publicly traded?
Yes, Ypsomed is publicly traded on SIX under the ticker symbol YPSN.
Who are Ypsomed's investors?
Ypsomed has 2 investors. Key investors include BV Partners, and TecMed Deutschland.
What is Ypsomed's ticker symbol?
The ticker symbol of Ypsomed is YPSN on SIX.